Mohr I, Bourhis H, Woimant F, Obadia MA, et al. Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HCl. J Gastroenterol Hepatol 2023;38:219-224.
PMID: 36331262